Open AccessMonotherapy versus combination therapy against nonbacteremic carbapenem-resistant gram-negative infections: a retrospective observational study
Author(s) -
Abdul Ghafur,
Vidyalakshmi Devarajan,
T Raja,
Jose Easow,
M A Raja,
Sankar Sreenivas,
R. Balasubramaniam,
SG Raman,
Dedeepiya Devaprasad,
Balaji Venkatachalam,
Ramesh Nimmagadda
Publication year - 2017
Publication title -
indian journal of critical care medicine/indian journal of critical care medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.317
H-Index - 30
eISSN - 1998-359X
pISSN - 0972-5229
DOI - 10.4103/ijccm.ijccm_243_17
Subject(s) - medicine , retrospective cohort study , odds ratio , pneumonia , carbapenem , combination therapy , meningitis , univariate analysis , confidence interval , multivariate analysis , antibiotics , surgery , microbiology and biotechnology , biology
Superiority of colistin-carbapenem combination therapy (CCCT) over colistin monotherapy (CMT) against carbapenem-resistant Gram-negative bacterial (CRGNB) infections is not conclusively proven.